Discovery of a fluoroquinolone-resistant Serratia marcescens clinical isolate without quinolone resistance-determining region mutations

• Published in: Annals of laboratory medicine Vol. 34; no. 6; pp. 487 - 488
• Main Authors: Yang, Haifei, Chen, Guosheng, Cheng, Jun, Liu, Yanyan, Hu, Lifen, Ye, Ying, Li, Jiabin
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Society for Laboratory Medicine 01.11.2014; 대한진단검사의학회
• Subjects: Aged; Anti-Bacterial Agents - pharmacology; Bacterial Proteins - genetics; Drug Resistance, Bacterial - genetics; Fluoroquinolones - pharmacology; Humans; Letter to the Editor; Male; Microbial Sensitivity Tests; Mutation; Serratia Infections - diagnosis; Serratia Infections - microbiology; Serratia marcescens - drug effects; Serratia marcescens - genetics; Serratia marcescens - isolation & purification; 병리학
• ISSN: 2234-3806; 2234-3814
• DOI: 10.3343/alm.2014.34.6.487

Sir, Serratia marcescens , once considered to be an innocuous and non-pathogenic organism, is now an important cause of hospital- acquired infections. This organism is associated with respiratory tract infections, urinary tract infections, septicemia, meningitis, and wound infections [1, 2]. S. marcescens infections are difficult to treat because of high resistance to a wide variety of antibiotics, including cephalosporins, fluoroquinolones, and aztreonam [2]. KCI Citation Count: 0